1075725-67-5

Basic information

• Product Name: N'-(3-allyl-2-hydroxybenzyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide
• Synonyms: N'-(3-allyl-2-hydroxybenzyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide
• CAS NO: 1075725-67-5
• Molecular Weight: 394.517
• Mol File: 1075725-67-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N'-(3-allyl-2-hydroxybenzyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: N'-(3-allyl-2-hydroxybenzyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide(1075725-67-5)
• EPA Substance Registry System: N'-(3-allyl-2-hydroxybenzyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide(1075725-67-5)

Safety Data

• Hazardous Substances Data: 1075725-67-5(Hazardous Substances Data)

Upstream product

• 361979-66-0 (4-benzyl-piperidin-1-yl)acetic acid ethyl ester 
• 414894-62-5 2-(4-benzylpiperidin-1-yl)acetohydrazide 
• 315183-21-2 2-(4-benzylpiperazin-1-yl)-N-[(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]acetamide 

Relevant articles and documents

DESIGN, SYNTHESIS AND EVALUATION OF PROCASPASE ACTIVATING COMPOUNDS AS PERSONALIZED ANTI-CANCER DRUGS

Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.

COMPOSITIONS AND METHODS INCLUDING CELL DEATH INDUCERS AND PROCASPASE ACTIVATION

Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3. In embodiments, compositions are capable of activation of procaspase-3.